What Does a Menopause Treatment Plan Actually Look Like? A Week-by-Week Breakdown

The majority of the women stepping into their initial menopause visit are unaware of what to anticipate. They are aware that they have symptoms. They have been exposed to MHT or hormone therapy and they most likely read mixed messages as to whether it is safe or not. More than that, there is scant knowledge about what actually goes on in the actual initiation of treatment and its subsequent outcomes.

This blog post makes it demystified. It takes a step-by-step look at how a treatment plan based on menopause will actually appear: the initial GP visit, the choices that will be made, the time by which we can expect things to improve, and what will the follow-up involve in the next weeks and months.

Before going further, it is worth noting that a menopause treatment plan cannot fit all people. Various women exhibit various symptoms, varying health records and also different preferences. There are those who will desire MHT, those who will not desire, those who will not be able to take it. The next section is a realistic image of how this process has a way of working out in the case of women going through it with a GP.

Before You Even Book the Appointment: What to Prepare

The most valuable item a woman can bring to her initial GP appointment concerning menopause is to monitor her symptoms. Physicians cannot determine the severity based on memory and an appointment consisting of a flimsy description of feeling off, or feeling asleep is far less productive than an appointment where definite patterns have been described.

It can be just a two to four-week diary. Record the number of hot flushes or night sweats that are occurring per day, the effect they are having on sleep, the changes in mood that may be occurring and the frequency, other symptoms that seem to be related to this such as joint pain, brain fog, vaginal dryness, anxiety, low libido. Record the frequency and how they are impacting daily activities or work.

A successful first appointment is based on this information. Jean Hailes for Women Health offers a free symptom checklist which is entirely dedicated to this task and the GP needs to make a thorough evaluation of which a completed version thereof will provide the GP with everything they need.

The First Appointment: What Happens

An actual menopause evaluation is not a five-minutes chat. An effective GP will desire to see the entire picture before give any advice.

Summarize your symptom profile: When you had them, their severity and the symptoms most disruptive to you. The GP will also examine your own history of health including a history of blood clots and cardiovascular disease, liver, and hormone-related cancers and anything that influences the processing of medications. Family history is also important, especially with respect to breast cancer, heart disease, and osteoporosis.

Mostly, being over 45 years old and having symptoms of the picture, a diagnosis of menopause does not need any blood tests. Due to the large fluctuation of the hormones during perimenopause, a single test result is not a good predictor. Typically, the change in cycle and symptoms (the clinical picture) suffice. Blood tests are not always required to diagnose menopause, though general health or thyroid (which may also have similarities with menopause symptoms) or blood lipids can be ordered to check them.

The GP will talk about the ways of treatment. These could involve MHT (menopausal hormone therapy), non-hormonal prescription drugs, lifestyle, or both. In the case of MHT, the kind of type which you will be advised to take will be determined by still having your uterus, your symptoms profile, and your health history.

What MHT Is

MHT is available in various forms and combinations. The active ingredient that primarily relieves symptoms, the oestrogen, comes in the form of a patch placed on skin, a gel to be applied daily, a spray or even in a pill. They mostly use patches and gels since they do not bypass the liver and are less likely to have the side effects of blood clots than tablets.

Women with their uterus intact must take a progestogen in combination with oestrogen, to shield the uterine lining against the stimulating action of oestrogen only. Most women prefer micronised progesterone, which is an identical form of progesterone used in the body. Oestrogen alone can be used by women who have undergone a hysterectomy.

The initial dose is usually low and the target is to seek the lowest dose that will be able to contain the symptoms. Doses can be varied as time passes on depending on the successes of symptom control and any incidences of side effects.

Weeks One and Two: What to Expect

MHT does not involve an overnight change. That is one of the most crucial things to comprehend since most of the women do not continue with treatment till the end since after one week they think that nothing has altered.

During the initial two weeks or so, a few women experience extremely faint changes. A nocturnal sweat may be a bit weaker. Sleep may be a little bit more disturbed. Others report a change in mood or a slight amelioration in vaginal dryness in days. It is absolutely normal that others will have no feelings at all at this point. The hormones are absorbing and body is starting to adjust.

The first few weeks also have some early side effects with some women having a bit of bleeding in the side in terms of breast tenderness or sensitivity, a little bloating, slight headaches or irregular spotting as long as periods have not ceased completely. These tend to be ordinary and usually resolve in the first month or two when the body is getting adjusted to new hormone levels. They do not warrant the discontinuation of treatment unless severe or concerning.

Weeks Three to Six: Meaningful Changes Start

In the majority of women, weeks three to six is the beginning of treatment where the treatment starts to feel like it is actually performing any action. It is during this period that hot flushes and night sweats usually begin to decrease in frequency and intensity. After menopause, many women complain that the number of flushes they experienced daily (at the time) has decreased to three or four.

Sleep usually works better at this stage, especially when the women who lost their rest mostly due to the night sweats. The more the sweats decrease, the more the repeated awakenings decrease, and deeper sleep will be possible.

Another area of development that tends to start showing some changes is mood between the fourth and sixth weeks. The frequent feeling of unease, or even depression, that tends to accompany the hormonal changes of the perimenopause begins to fade as oestrogen and progesterone levels become normal. Other women call this returning to themselves as opposed to being dramatic.

It is also after this time that it becomes apparent as to whether the initial dose is effective or whether the dose will have to be changed. Having made no significant headway in terms of improvement in terms of symptoms by week four or six is also good information to revert to the GP. This does not imply that the treatment is not working. It usually implies that the dose must be increased, or that the route of administration must change, as well.

Months Two and Three: Stabilisation and Review

At the end of the second and the beginning of the third month, a picture becomes much clearer. Hot flushes, night sweats and disrupted sleep have been the key symptoms, which improve significantly in most women. By this age, many of the women have seen a reduction in the frequency of a flush by 70 to 80 per cent. Energy, focus, mood tends to feel a lot more stable.

Other symptoms are delayed. It is the vaginal dryness that generally gets better over time. This may be supplemented with local vaginal oestrogen which can be administered on top of systemic MHT and which is applied directly to the tissue in need. Vaginal tissue needs up to eight to more than a dozen weeks of active use to completely recover.

It is approximately at the same time as the initial scheduled follow-up appointment. Australasian Menopause Society suggests that MHT should be reconsidered between six to twelve weeks of starting to determine the reaction to symptoms and any side effects and then regularly thereafter. Doses are revised, alternative formulations are discussed where necessary, and any issues are resolved at the review.

The Follow-Up: What a Good Review Looks Like

The six- to twelve-week follow-up is not a tick box activity. It is a real evaluation of the current state of affairs and where treatment is fine-tuned.

The GP will be interested in: what are the symptom improvements and by which percent, are there any persistent side effects, are there new symptoms, has the period changed and does it persist, and is there anything that is not sufficiently addressed.

The symptom journal which began the week prior to the initial visit, which continued through the initial weeks of treatment, gives exactly the sort of specific, measurable data which render this review most beneficial. Instead of telling about things feeling better, telling how things have changed: used to have a dozen a day, now only three times, used to have four disturbances a night, now one, etc., is what the GP is able to depend on in order to come up with well-informed decision to continue or modify.

After Three Months: The Longer-Term Picture

The initial three months is the active adjustment phase to most women who respond well to MHT. Then the treatment will settle into routine. Reviewing with a GP annually helps keep the prescription in order and has any consideration of new health needs taken into consideration.

MHT is considered safe in most cases in healthy women between the ages of 50-60 years or during the first decade of menopause. The small risks are generally less than the benefits of transition therapy on women in this window in terms of controlling their symptoms, preserving bone and heart health. The discussion on the time of continuations of MHT is personalized and it is every year, after evaluating the current health conditions, symptoms and any other emerging facts.

Interestingly to note, maintaining bone density protection will necessitate continued MHT. When MHT is discontinued, bone loss reappears, and it is faster than usual during the first four to five years of discontinuation. This can only be taken into consideration especially when the women experience menopause prematurely or when they have bone density risk factors.

What Happens When MHT Is Not an Option

All women are not able, or want to take MHT. In women who have a history of sensitivity to oestrogen in breast cancer, some blood clotting disorders or other contraindications, non-hormonal strategies become the foundation of the treatment strategy.

The non-hormonal medications used in control of hot flushes and night sweats are some antidepressants at low doses (most commonly venlafaxine and escitalopram) but also gabapentin and the new drug fezolinetant, which is specifically approved to treat menopause vasomotor symptoms and is currently approved by TGA in Australia. They are prescribed by a GP and can help a large percentage of the women.

Cognitive behavioural therapy (CBT-I) has high levels of evidence about the insomnia and mood aspects of menopause and is still the first-line treatment of insomnia whether MHT is in use or not.

The core of management involving all women is lifestyle approaches that encompass exercise, music, sleeping habits, stress management and avoidance of triggers, which can be incorporated with medical treatment, of which it does not serve to replace medical treatment but rather as supplementary.

The Most Underrated Part of the Plan: Tracking

A simple record of symptoms at any phase of a menopause treatment plan has a significant difference to results. It assists the GP in making decisions preferred. It helps the woman herself realise progress that occurs over time and that would otherwise be unnoticed. And it gives advance detection when something is not going on or when a dose readjustment is necessary.

It need not be gilded. There is a morning step on a phone, assessing the amount of sleep that night before, the amount of flushes, and the overall mood out of ten. This step only takes about thirty seconds. That builds a pattern which is much more helpful than attempting to remember how things were a month ago when sitting in a consulting room.

Final Thoughts

There is no single decision about a menopause treatment plan. It is not a one-time event: the initial appointment made with knowledge, the approach has been selected, a period of adaptation with a clear understanding of time, a follow-up until the plan is adjusted hereafter and the annual reviews are done as the life and health change.

The greatest thing is not giving up treatment during the early weeks before it can work, not to believe that a treatment failure without eight to twelve weeks is possible, and to remain in contact with a GP who has an overview of the menopause terrain.

It is really worth the effort in getting the menopause management right. The gap between coping with this transition successfully and failing to cope with it entirely becomes evident, not only over the immediate few months, but also in bone density, cardiovascular well-being, cognitive performance, and quality of life during the decades to come.